Serial Number
77766816
Owner
Lupin Pharmaceuticals, Inc.Attorney
Robert L. PowleyFiling Date
Jun 24, 2009
LUPIN Trademark
Serial Number: 77766816 • Registration: 4874579
Trademark Classes
Owner Contact Info
21st Floor, HarborPlace Tower
Baltimore, MD 21202
Entity Type: 03
Legal Representation
Correspondence Address
Robert L. Powley Powley & Gibson, P.C.
60 Hudson Street
Suite 2203
New York, NY 10013
United States
Trademark Details
Filing Date
June 24, 2009
Registration Date
December 22, 2015
Published for Opposition
February 28, 2012
Goods & Services
Pharmaceutical preparations for the treatment of infectious and parasitic diseases; antibiotics; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine and metabolic systems; pharmaceutical preparations for the treatment of mental and behavioral conditions and disorders; antidepressants; pharmaceutical preparations for the treatment of diseases and disorders of the nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the eye and adnexa; pharmaceutical preparations for the treatment of diseases and disorders of the ear and mastoid process; pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system; antihypertensives; pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for the treatment of diseases and disorders of the digestive system; pharmaceutical preparations for the treatment of diseases and disorders of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal system and connective tissue; pharmaceutical preparations for the treatment of diseases and conditions of the genitourinary system; and pharmaceutical preparations for the treatment of diseases and disorders associated with pregnancy, childbirth and the peurperium, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation